IE

Ida Ebenezar

Active Director Director DIN 08410477
DIN 08410477 First appointment Apr 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2020
Shareholding value •••• Premium profile

About Ida Ebenezar

Data last updated:

Ida Ebenezar is a Director at Duncan Pharma Private Limited (since 2020). The company operates in Pharma. Duncan Pharma Private Limited reported revenue of ₹22.9 Lakh (FY 2020).

DIN 08410477
Primary Designation Director
Industry Pharma
First Appointment 20 Apr 2020
Oldest Company Age 21 yrs
Largest company Duncan Pharma Private Limited · ₹22.9 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Duncan Pharma Private Limited U24231TN2005PTC056343
Director20 Apr 20202005₹22.9 Lakh (FY 2020)Active

Board colleagues of Ida Ebenezar

NameDINCompanyDesignation
Varadarajan Dhivyalakshmi08735533Duncan Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Duncan Pharma Private Limited
Premium access

Shareholding and investment profile for Ida Ebenezar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ida Ebenezar

Ida Ebenezar currently holds 1 directorship: Duncan Pharma Private Limited (Director, since 20 Apr 2020, revenue ₹22.9 Lakh (FY 2020)).

Ida Ebenezar was first appointed on 20 Apr 2020 as Director at Duncan Pharma Private Limited.

The current boards of Ida Ebenezar's companies include Varadarajan Dhivyalakshmi (Duncan Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available